GAUMOND MEDICAL GROUP INC. (GMG) is a dynamic and innovative Canadian company specialized in biomedical engineering. GMG is dedicated to the research and development of transportable hyperbaric technologies and works in the field of composite materials.

Since its creation, GMG has distinguished itself by its willingness to break new ground in the design of hyperbaric devices. The use of composite materials of high performance is one of the peculiarities of GMG.  Over the years, GMG has become a pioneer in this specifis field.


The mission of GMG is to democratize  hyperbaric oxygen therapy (HBOT) through the development of innovative solutions. HBOT is a therapy that improves the quality of life and health of people suffering from pathologies recognized by the Undersea and Hyperbaric Medical Society (UHMS). In some cases HBOT is an auxiliary therapy, while in others it is the only known therapy.

However, HBOT is still commonly unknown from the public mainly due to the expensive cost of equipment required for its application.  We can now proudly say that a new alternative is born for effective HBOT treatments.